Sarcoidosis vasculitis and diffuse lung diseases

Published: 2013-09-01

Editorial

Section 1: Update on idiopathic pulmonary fibrosis: epidemiology, natural history, disease staging and pathogenesis

Epidemiology of idiopathic pulmonary fibrosis in Europe – an update

I. Annesi-Maesano, H. Nunes, B. Duchemann, et al.
Abstract 329 | PDF Downloads 83

Page 6-12

Classification, natural history and staging of idiopathic pulmonary fibrosis

V. Poletti, J. Egan
Abstract 238 | PDF Downloads 67

Page 13-20

Section 2: Update on idiopathic pulmonary fibrosis: pathophysiology and future perspectives

Molecular biomarkers in idiopathic pulmonary fibrosis and disease severity

B. Crestani
Abstract 121 | PDF Downloads 40

Page 27-32

Section 3: Management of idiopathic pulmonary fibrosis and implications for clinical practice - A case study series

Management of idiopathic pulmonary fibrosis and pulmonary hypertension

K. Schulze
Abstract 92 | PDF Downloads 45

Page 33-36

Gastro-oesophageal reflux and idiopathic pulmonary fibrosis

C. Vancheri
Abstract 94 | PDF Downloads 53

Page 37-39

Pirfenidone treatment in a patient with IPF and possible initial hypersensitivity pulmonitis

F. Cinetto, C. Agostini
Abstract 117 | PDF Downloads 45

Page 40-43

Management of a patient with familial idiopathic pulmonary fibrosis

S. Böing, S. George, L. Hagmeyer
Abstract 89 | PDF Downloads 67

Page 48-51

Long-term management of IPF with pirfenidone – a clinical case study with 5 years follow-up

L. Richeldi, G. Sgalla, S. Cerri
Abstract 185 | PDF Downloads 57

Page 52-62

Conclusions